This post has the latest update on KOSPI 200 June rebalancing and examines SK Bioscience's KOSPI 200 fast entry situation along with a likely deletion resulting from it.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.